News Home

IGC Pharma Inc (IGC) Stock: What Does the Chart Say Tuesday?

Tuesday, February 27, 2024 12:39 PM | InvestorsObserver Analysts

Mentioned in this article

IGC Pharma Inc (IGC) Stock: What Does the Chart Say Tuesday?

The market has been high on IGC Pharma Inc (IGC) stock recently. IGC gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
IGC Pharma Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on IGC!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With IGC Stock Today?

IGC Pharma Inc (IGC) stock is trading at $0.34 as of 12:32 PM on Tuesday, Feb 27, a decline of -$0.01, or -2.55% from the previous closing price of $0.35. The stock has traded between $0.32 and $0.37 so far today. Volume today is 300,339 compared to average volume of 397,913. To screen for more stocks like IGC Pharma Inc click here.

More About IGC Pharma Inc

India Globalization Capital Inc is an investment holding company. The company's operating segment includes Infrastructure and Life Sciences. It generates maximum revenue from the Life Sciences segment. The Infrastructure Business segment involves the execution of construction contracts, the rental of heavy construction equipment, and the purchase and resale of physical commodities used in infrastructure. The Life Sciences Segment includes biopharmaceuticals and Over the Counter Products Geographically, it derives a majority of revenue from Hong Kong and also has a presence in India. Click Here to get the full Stock Report for IGC Pharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App